Cancer Research UK
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 1K
- Market Cap
- -
Interferon Alfa With or Without Thalidomide in Treating Patients With Metastatic Kidney Cancer
Phase 2
- Conditions
- Kidney Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-08-07
- Lead Sponsor
- Cancer Research UK
- Target Recruit Count
- 90
- Registration Number
- NCT00027664
- Locations
- π¬π§
Beatson West of Scotland Cancer Centre, Glasgow, Scotland, United Kingdom
π¬π§Oxford Radcliffe Hospital, Oxford, England, United Kingdom
π¬π§Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath